Extracellular regulated protein kinases play a key role via bone morphogenetic protein 4 in high phosphate-induced

Ling Qin1, Bo Tang1, Bingqing Deng1

  • 1Department of Nephrology & Rheumatology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.

Life Sciences
|April 22, 2015
PubMed
Abstract

Insights

In chronic kidney disease, high phosphate induces endothelial cell apoptosis. Inhibiting ERK MAPK upregulates bone morphogenetic protein 4 (BMP4), protecting cells from hyperphosphatemia-induced damage.

Area of Science:

  • Cardiovascular biology
  • Endothelial cell function
  • Molecular mechanisms of kidney disease

Background:

  • Hyperphosphatemia is a significant risk factor for cardiovascular events in chronic kidney disease patients.
  • High phosphate levels are known to induce endothelial cell apoptosis, but the underlying mechanisms require elucidation.
  • Understanding these mechanisms is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the molecular mechanisms by which high phosphate induces apoptosis in human umbilical vein endothelial cells (HUVECs).
  • To identify key genes and pathways involved in hyperphosphatemia-induced endothelial cell apoptosis.
  • To explore potential therapeutic targets for mitigating cardiovascular risks associated with chronic kidney disease.

Main Methods:

  • Microarray analysis of HUVECs cultured in high (3.0mM) versus normal (1.0mM) phosphate conditions.
  • Bioinformatic analysis to identify differentially expressed genes and key signaling pathways, including MAPK.
  • Validation of microarray findings using Annexin V/PI staining, caspase-3 cleavage assays, immunoblotting, and quantitative real-time PCR.
  • Assessment of the role of bone morphogenetic protein 4 (BMP4) and extracellular signal-regulated kinases (ERKs) in high phosphate-induced apoptosis.

Main Results:

  • Microarray analysis identified the mitogen-activated protein kinase (MAPK) pathway as critical.
  • Gene coexpression network analysis suggested bone morphogenetic protein 4 (BMP4) as a key regulatory gene, with its expression decreased under high phosphate conditions.
  • Extracellular regulated protein kinases (ERKs) were activated; however, inhibiting ERK with U0126 increased BMP4 expression and reduced endothelial cell apoptosis.
  • Pretreatment with BMP4 protein also reduced apoptosis, but did not affect ERK MAPK activation, suggesting a parallel protective pathway.

Conclusions:

  • Inhibition of the ERK MAPK pathway protects endothelial cells from hyperphosphatemia-induced apoptosis by upregulating BMP4.
  • This study identifies a novel mechanism linking high phosphate, ERK MAPK, BMP4, and endothelial cell apoptosis.
  • The findings provide potential molecular targets for novel therapeutic strategies to reduce endothelial cell apoptosis and cardiovascular events in chronic kidney disease.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.6K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.1K